Answers are grounded in this paper and cite their sources.
The neonatal period in dairy calves features high susceptibility to oxidative stress and enteric diseases. We evaluated a single neonatal Vitamin AD3E injection's effect on growth, nutrient digestibility, antioxidant status, and serum biomarkers of the thyroid-metabolic axis. Twenty newborn Holstein males were randomly assigned to a Control or AD3E group (subcutaneous injection, day 7) and monitored until day 91. The injection reduced diarrhea incidence (2 vs. 4 calves; P=0.001) and duration (2.5 vs. 4.0 days; P=0.033). Treated calves exhibited higher NDF (56.88% vs. 50.17%; P=0.002) and ADF (62.19% vs. 57.67%; P<0.001) digestibility. Systemically, AD3E increased antioxidant enzymes (GPx: 6.95 vs. 5.78 nmol/mg; SOD: 0.61 vs. 0.55 U/mg; Catalase: 30.77 vs. 26.80 U/mL; P<0.05). Furthermore, treated calves had higher serum T3 (10.88 vs. 9.63 nmol/L) and T4 (106.99 vs. 97.12 nmol/L) (P<0.01), and lower LDH activity (237.11 vs. 262.67 U/L; P=0.001). Consequently, treated calves achieved higher final body weights (107.67 vs. 101.08 kg; P=0.048) and average daily gain (792.25 vs. 729.89 g/d; P=0.011). In conclusion, early-life Vitamin AD3E improved health, digestibility, and growth. These outcomes are likely associated with enhanced antioxidant capacity and potentially favorable metabolic modulations, enhancing calf resilience.
No takes yet. Share an insight, caveat, or question.
Asadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: